Diabetes Care
Worldwide leading in the area of blood glucose monitoring
Individual needs of patients – tailored development of products
Our Diabetes Care division focuses its research and development activities on strengthening its core product lines and on expanding into high growth/high margin segments of the market. Through internal development activities and collaborations with partners, we are able to offer mass market, user-friendly whole blood glucose monitoring systems, meeting the individual needs of patients with diabetes.
We are actively researching a minimally invasive system which requires only a small blood sample and has a short testing time. Beyond these research and development projects, we are investing in technologies that will allow glucose monitoring without painful invasive sampling of body fluids. One example of our expansion into new segments of the diabetes market is the acquisition of the U.S.-based company, Metrika, headquartered in Sunnyvale, California, in July 2006. Metrika manufactures and markets a new type of handheld glucose-monitoring system capable of measuring the long-term glucose parameter HbA1c, also known as glycated hemoglobin.
